Enzyme Replacement Therapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064004
  • May 2021
  • Biotechnology
  • 131 Pages
The Enzyme Replacement Therapy Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Shire Plc, Sanofi S.A, Biomarin Pharmaceutical Inc., AbbVie, Alexion Pharmaceuticals Inc., Allergan plc., Horizon Pharma Public Limited Company, Actelion (Janssen), Recordati Rare Diseases, Protalix Biotherapeutics, Amicus Therapeutics, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Enzyme Replacement Therapy market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Enzyme Replacement Therapy market is expected to attain Pre COVID-19 levels by mid-2022.

Enzyme Replacement Therapy Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Enzyme Replacement Therapy market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Enzyme Replacement Therapy Market Competitive and Premeditated Analysis
In the Enzyme Replacement Therapy report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Enzyme Replacement Therapy research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Enzyme Replacement Therapy Market:
The Enzyme Replacement Therapy market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Shire Plc, Sanofi S.A, Biomarin Pharmaceutical Inc., AbbVie, Alexion Pharmaceuticals Inc., Allergan plc., Horizon Pharma Public Limited Company, Actelion (Janssen), Recordati Rare Diseases, Protalix Biotherapeutics, Amicus Therapeutics, Inc.

The Enzyme Replacement Therapy market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Enzyme Replacement Therapy Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Enzyme Replacement Therapy market:
ByEnzyme Type
Pegademase
Velaglucerase Alfa
Agalsidase Beta
Imiglucerase
Taliglucerase
Laronidase
Alglucosidase Alfa
Galsulfase
Idursulfase
Pancreatic Enzymes
Other Enzymes
Therapeutic Conditions
Gaucher\'s Disease
Fabry\'s Disease
Pompe\'s Disease
SCID
MPS
Others

Regional Analysis of the Enzyme Replacement Therapy market:
The Enzyme Replacement Therapy market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Enzyme Replacement Therapy report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Enzyme Replacement Therapy market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Enzyme Replacement Therapy market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Enzyme Replacement Therapy market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Enzyme Replacement Therapy market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Enzyme Replacement Therapy market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Enzyme Replacement Therapy market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Enzyme Replacement Therapy market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Enzyme Replacement Therapy market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Shire Plc
  • Sanofi S.A
  • Biomarin Pharmaceutical Inc.
  • AbbVie
  • Alexion Pharmaceuticals Inc.
  • Allergan plc.
  • Horizon Pharma Public Limited Company
  • Actelion (Janssen)
  • Recordati Rare Diseases
  • Protalix Biotherapeutics
  • Amicus Therapeutics, Inc.
  • Pegademase
  • Velaglucerase Alfa
  • Agalsidase Beta
  • Imiglucerase
  • Taliglucerase
  • Laronidase
  • Alglucosidase Alfa
  • Galsulfase
  • Idursulfase
  • Pancreatic Enzymes
  • Other Enzymes
  • Gaucher's Disease
  • Fabry's Disease
  • Pompe's Disease
  • SCID
  • MPS
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Enzyme Replacement Therapy Market Snapshot
          2.1.1. Global Enzyme Replacement Therapy Market By Enzyme Type,2019
               2.1.1.1.Pegademase
               2.1.1.2.Velaglucerase Alfa
               2.1.1.3.Agalsidase Beta
               2.1.1.4.Imiglucerase
               2.1.1.5.Taliglucerase
               2.1.1.6.Laronidase
               2.1.1.7.Alglucosidase Alfa
               2.1.1.8.Galsulfase
               2.1.1.9.Idursulfase
               2.1.1.10.Pancreatic Enzymes
               2.1.1.11.Other Enzymes
          2.1.2. Global Enzyme Replacement Therapy Market By Therapeutic Conditions,2019
               2.1.2.1.Gaucher's Disease
               2.1.2.2.Fabry's Disease
               2.1.2.3.Pompe's Disease
               2.1.2.4.SCID
               2.1.2.5.MPS
               2.1.2.6.Others
          2.1.3. Global Enzyme Replacement Therapy Market By End-use,2019
          2.1.4. Global Enzyme Replacement Therapy Market By Geography,2019

3. Global Enzyme Replacement Therapy Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Enzyme Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Enzyme Type, 2020
     4.2. Global Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028

5. Global Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Therapeutic Conditions, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Therapeutic Conditions, 2020
     5.2. Global Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028

6. Global Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028

7. Global Enzyme Replacement Therapy Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Enzyme Replacement Therapy Market Analysis, 2018 – 2028 
          7.2.1. North America Enzyme Replacement Therapy Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028
          7.2.3. North America Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028
          7.2.4. North America Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Enzyme Replacement Therapy Market Analysis, 2018 – 2028 
          7.3.1.  Europe Enzyme Replacement Therapy Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028
          7.3.3. Europe Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028
          7.3.4. Europe Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Enzyme Replacement Therapy Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Enzyme Replacement Therapy Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028
          7.4.3. Asia Pacific Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028
          7.4.4. Asia Pacific Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Enzyme Replacement Therapy Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Enzyme Replacement Therapy Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028
          7.5.3. Latin America Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028
          7.5.4. Latin America Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Enzyme Replacement Therapy Market Analysis, 2018 – 2028 
          7.6.1.  MEA Enzyme Replacement Therapy Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Enzyme Replacement Therapy Market Size (US$), By Enzyme Type, 2018 – 2028
          7.6.3. MEA Enzyme Replacement Therapy Market Size (US$), By Therapeutic Conditions, 2018 – 2028
          7.6.4. MEA Enzyme Replacement Therapy Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Enzyme Replacement Therapy Providers
        8.4.1 Shire Plc
                8.4.1.1 Business Description
                8.4.1.2 Shire Plc Geographic Operations
                8.4.1.3 Shire Plc Financial Information
                8.4.1.4 Shire Plc Product Positions/Portfolio
                8.4.1.5 Shire Plc Key Developments
        8.4.2 Sanofi S.A
                8.4.2.1 Business Description
                8.4.2.2 Sanofi S.A Geographic Operations
                8.4.2.3 Sanofi S.A Financial Information
                8.4.2.4 Sanofi S.A Product Positions/Portfolio
                8.4.2.5 Sanofi S.A Key Developments
        8.4.3 Biomarin Pharmaceutical Inc.
                8.4.3.1 Business Description
                8.4.3.2 Biomarin Pharmaceutical Inc. Geographic Operations
                8.4.3.3 Biomarin Pharmaceutical Inc. Financial Information
                8.4.3.4 Biomarin Pharmaceutical Inc. Product Positions/Portfolio
                8.4.3.5 Biomarin Pharmaceutical Inc. Key Developments
        8.4.4 AbbVie
                8.4.4.1 Business Description
                8.4.4.2 AbbVie Geographic Operations
                8.4.4.3 AbbVie Financial Information
                8.4.4.4 AbbVie Product Positions/Portfolio
                8.4.4.5 AbbVie Key Developments
        8.4.5 Alexion Pharmaceuticals Inc.
                8.4.5.1 Business Description
                8.4.5.2 Alexion Pharmaceuticals Inc. Geographic Operations
                8.4.5.3 Alexion Pharmaceuticals Inc. Financial Information
                8.4.5.4 Alexion Pharmaceuticals Inc. Product Positions/Portfolio
                8.4.5.5 Alexion Pharmaceuticals Inc. Key Developments
        8.4.6 Allergan plc.
                8.4.6.1 Business Description
                8.4.6.2 Allergan plc. Geographic Operations
                8.4.6.3 Allergan plc. Financial Information
                8.4.6.4 Allergan plc. Product Positions/Portfolio
                8.4.6.5 Allergan plc. Key Developments
        8.4.7 Horizon Pharma Public Limited Company
                8.4.7.1 Business Description
                8.4.7.2 Horizon Pharma Public Limited Company Geographic Operations
                8.4.7.3 Horizon Pharma Public Limited Company Financial Information
                8.4.7.4 Horizon Pharma Public Limited Company Product Positions/Portfolio
                8.4.7.5 Horizon Pharma Public Limited Company Key Developments
        8.4.8 Actelion (Janssen)
                8.4.8.1 Business Description
                8.4.8.2 Actelion (Janssen) Geographic Operations
                8.4.8.3 Actelion (Janssen) Financial Information
                8.4.8.4 Actelion (Janssen) Product Positions/Portfolio
                8.4.8.5 Actelion (Janssen) Key Developments
        8.4.9 Recordati Rare Diseases
                8.4.9.1 Business Description
                8.4.9.2 Recordati Rare Diseases Geographic Operations
                8.4.9.3 Recordati Rare Diseases Financial Information
                8.4.9.4 Recordati Rare Diseases Product Positions/Portfolio
                8.4.9.5 Recordati Rare Diseases Key Developments
        8.4.10 Protalix Biotherapeutics
                8.4.10.1 Business Description
                8.4.10.2 Protalix Biotherapeutics Geographic Operations
                8.4.10.3 Protalix Biotherapeutics Financial Information
                8.4.10.4 Protalix Biotherapeutics Product Positions/Portfolio
                8.4.10.5 Protalix Biotherapeutics Key Developments
        8.4.11 Amicus Therapeutics, Inc.
                8.4.11.1 Business Description
                8.4.11.2 Amicus Therapeutics, Inc. Geographic Operations
                8.4.11.3 Amicus Therapeutics, Inc. Financial Information
                8.4.11.4 Amicus Therapeutics, Inc. Product Positions/Portfolio
                8.4.11.5 Amicus Therapeutics, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Enzyme Replacement Therapy Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Enzyme Replacement Therapy Market Revenue, By Enzyme Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Enzyme Replacement Therapy Market Revenue, By Therapeutic Conditions, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Enzyme Replacement Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Enzyme Replacement Therapy Market Revenue, By Enzyme Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Enzyme Replacement Therapy Market Revenue, By Therapeutic Conditions, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Enzyme Replacement Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Enzyme Replacement Therapy Market Revenue, By Enzyme Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Enzyme Replacement Therapy Market Revenue, By Therapeutic Conditions, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Enzyme Replacement Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Enzyme Replacement Therapy Market Revenue, By Enzyme Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Enzyme Replacement Therapy Market Revenue, By Therapeutic Conditions, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Enzyme Replacement Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Enzyme Replacement Therapy Market Revenue, By Enzyme Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Enzyme Replacement Therapy Market Revenue, By Therapeutic Conditions, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Enzyme Replacement Therapy Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Enzyme Replacement Therapy: Market Segmentation 
FIG. 2 Global Enzyme Replacement Therapy Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Enzyme Replacement Therapy Market, By Enzyme Type, 2019 (US$ Mn) 
FIG. 5 Global Enzyme Replacement Therapy Market, By Therapeutic Conditions, 2019 (US$ Mn) 
FIG. 6 Global Enzyme Replacement Therapy Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Enzyme Replacement Therapy Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Enzyme Replacement Therapy Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Enzyme Replacement Therapy Providers, 2019
FIG. 11 Global Enzyme Replacement Therapy Market Revenue Contribution, By Enzyme Type, 2019 & 2028 (Value %) 
FIG. 12 Global Enzyme Replacement Therapy Market Revenue Contribution, By Therapeutic Conditions, 2019 & 2028 (Value %) 
FIG. 13 Global Enzyme Replacement Therapy Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Enzyme Replacement Therapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Enzyme Replacement Therapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Enzyme Replacement Therapy Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Enzyme Replacement Therapy Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Enzyme Replacement Therapy Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Enzyme Replacement Therapy market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Enzyme Replacement Therapy Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Enzyme Replacement Therapy Market Value, By Segment1, 2018 – 2028
TABLE  North America Enzyme Replacement Therapy Market Value, By Segment2, 2018 – 2028
TABLE  North America Enzyme Replacement Therapy Market Value, By Country, 2018 – 2028
TABLE  Europe Enzyme Replacement Therapy Market Value, By Segment1, 2018 – 2028
TABLE  Europe Enzyme Replacement Therapy Market Value, By Segment2, 2018 – 2028
TABLE  Europe Enzyme Replacement Therapy Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Enzyme Replacement Therapy Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Enzyme Replacement Therapy Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Enzyme Replacement Therapy Market Value, By Country, 2018 – 2028
TABLE  Latin America Enzyme Replacement Therapy Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Enzyme Replacement Therapy Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Enzyme Replacement Therapy Market Value, By Country, 2018 – 2028
TABLE  MEA Enzyme Replacement Therapy Market Value, By Segment1, 2018 – 2028
TABLE  MEA Enzyme Replacement Therapy Market Value, By Segment2, 2018 – 2028
TABLE  MEA Enzyme Replacement Therapy Market Value, By Country, 2018 – 2028
TABLE  Shire Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi S.A: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biomarin Pharmaceutical Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AbbVie: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Alexion Pharmaceuticals Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergan plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Horizon Pharma Public Limited Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Actelion (Janssen): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Recordati Rare Diseases: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Protalix Biotherapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amicus Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Enzyme Replacement Therapy Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Enzyme Replacement Therapy Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Enzyme Replacement Therapy Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Enzyme Replacement Therapy Market, By Geography, 2019 (US$ Mn)
FIG.  Global Enzyme Replacement Therapy Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Enzyme Replacement Therapy Providers, 2016
FIG.  Global Enzyme Replacement Therapy Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Velaglucerase Alfa Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Agalsidase Beta Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Imiglucerase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Taliglucerase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Laronidase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Alglucosidase Alfa Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Galsulfase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Idursulfase Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pancreatic Enzymes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Enzymes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Enzyme Replacement Therapy Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Fabry's Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pompe's Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global SCID Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global MPS Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Enzyme Replacement Therapy Market Value, 2018 – 2028, (US$ Mn)